您的位置: 首页 > 2018年1月 第49卷 第1期 > 文字全文
2023年7月 第38卷 第7期11
目录

瘦素对高血压肾损害相关机制的研究进展

Advances in research on the mechanism of leptin on hypertensive renal damage

来源期刊: 广州医药 | 110-113 发布时间:2021-12-01 收稿时间:2025/11/13 17:25:59 阅读量:166
作者:
关键词:
瘦素瘦素抵抗高血压肾损害氧化应激
LeptinLeptin resistanceHypertensionRenal damageOxidative stress
DOI:
10.3969/j.issn.1000-8535.2018.01.032
收稿时间:
2017-09-19 
修订日期:
 
接收日期:
 
引用总数:
0  
瘦素(leptin)是由控制各种生理过程的脂肪组织合成和分泌的一类激素,通过作用于靶细胞膜上的瘦素受体并经信号传导在各器官和系统中发挥一系列生物学效应。肾脏是高血压常见的靶器官之一。相关研究表明,瘦素在高血压肾损害中发挥作用,其机制可能与氧化应激及其炎症反应有关。本文以瘦素对高血压肾损害及其相关机制作一综述,并探讨瘦素对高血压肾损害发病机制研究进展。
Leptin which is a kind of synthesis and secretion of hormone that participates in various physiological processes is the role of the leptin receptor on the target cell membrane and the signal transduction through a series of biological effects in different organs and systems. Kidney is one of the common target organs of hypertension, and related research shows that leptin plays a role in hypertensive kidney damage, whose mechanism may be related to oxidative stress and its inflammatory reaction. The paper reviewed leptin on renal damage in hypertension and its related mechanisms, to explore the leptin on renal pathogenesis of hypertension research progress.
1、 SALEH MA, NORLANDER A E, MADHUR M S. Inhibition of interleukin 17-a but not interleukin-17f signaling lowers blood pressure and reduces end-organ inflammation in angiotensin ii-induced hypertension[J]. JACC Basic Transl Sci,2016, 1(7): 606-616. SALEH MA, NORLANDER A E, MADHUR M S. Inhibition of interleukin 17-a but not interleukin-17f signaling lowers blood pressure and reduces end-organ inflammation in angiotensin ii-induced hypertension[J]. JACC Basic Transl Sci,2016, 1(7): 606-616.
2、 KRISHNAN S M, SOBEY C G, LATZ E, et al. IL-1β and IL-18: inflammatory markers or mediators of hypertension? [J]. Br J Pharmacol,2014, 171(24): 5589-5602. KRISHNAN S M, SOBEY C G, LATZ E, et al. IL-1β and IL-18: inflammatory markers or mediators of hypertension? [J]. Br J Pharmacol,2014, 171(24): 5589-5602.
3、 AGHARAZII M, ST-LOUIS R, GAUTIER-BASTIEN A, et al. Inflammatory cytokines and reactive oxygen species as mediators oI chronic kidney disease-related vascular calcflication[J]. Am J Hypertens, 2015, 28(6): 746-755. AGHARAZII M, ST-LOUIS R, GAUTIER-BASTIEN A, et al. Inflammatory cytokines and reactive oxygen species as mediators oI chronic kidney disease-related vascular calcflication[J]. Am J Hypertens, 2015, 28(6): 746-755.
4、 HE P, LI D, ZHANG B. Losartan attenuates renal interstitial fibrosis and tubular cell apoptosis in a rat model of obstructive nephropathy[J]. Mol Med Rep, 2014, 10(2): 638-644. HE P, LI D, ZHANG B. Losartan attenuates renal interstitial fibrosis and tubular cell apoptosis in a rat model of obstructive nephropathy[J]. Mol Med Rep, 2014, 10(2): 638-644.
5、 YAO J, KE Z, WANG X, et al. Epithelial-mesenchymal transition and apoptosis of renal tubular epithelial cells are associated with disease progression in patients with IgA nephropathy[J]. Mol Med Rep, 2014, 10(1): 39-44. YAO J, KE Z, WANG X, et al. Epithelial-mesenchymal transition and apoptosis of renal tubular epithelial cells are associated with disease progression in patients with IgA nephropathy[J]. Mol Med Rep, 2014, 10(1): 39-44.
6、 MARTINEZ-USEROS J, LI W, CABEZA-MORALES M, et al. Oxidative stress: a new target for pancreatic cancer prognosis and treatment[J]. J Clin Med, 2017, 6(3): 29. MARTINEZ-USEROS J, LI W, CABEZA-MORALES M, et al. Oxidative stress: a new target for pancreatic cancer prognosis and treatment[J]. J Clin Med, 2017, 6(3): 29.
7、 KAMATO D, BURCH M L, PIVA T J, et al. Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation[J]. Cell Signal, 2013, 25(10): 2017-2024. KAMATO D, BURCH M L, PIVA T J, et al. Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation[J]. Cell Signal, 2013, 25(10): 2017-2024.
8、 BOILAN E, WINANT V, DUMORTIER E, et al. Role of p38MAPK and oxidative stress in copper-induced senescence[J]. AGE, 2013, 35(6): 2255-2271. BOILAN E, WINANT V, DUMORTIER E, et al. Role of p38MAPK and oxidative stress in copper-induced senescence[J]. AGE, 2013, 35(6): 2255-2271.
9、 ROGOBETE A F, SANDESC D, PAPURICA M, et al. The influence of metabolic imbalances and oxidative stress on the outcome of critically ill polytrauma patients: a review[J]. Burns Trauma, 2017, 5(1): 8. ROGOBETE A F, SANDESC D, PAPURICA M, et al. The influence of metabolic imbalances and oxidative stress on the outcome of critically ill polytrauma patients: a review[J]. Burns Trauma, 2017, 5(1): 8.
10、 DING N, LIU B, SONG J, et al. Leptin promotes endothelial dysfunction in chronic kidney disease through AKT/GSK3β and β-catenin signals[J]. Biochem Biophys Res Commun, 2016, 480(4): 544-551. DING N, LIU B, SONG J, et al. Leptin promotes endothelial dysfunction in chronic kidney disease through AKT/GSK3β and β-catenin signals[J]. Biochem Biophys Res Commun, 2016, 480(4): 544-551.
11、 GOTO K, KANEKO Y, SATO Y,et al. Leptin deficiency down-regulates IL-23 production in glomerular podocytes resulting in an attenuated immune response in nephrotoxic serum nephritis[J]. Int Immunol, 2016, 28(4): 197-208. GOTO K, KANEKO Y, SATO Y,et al. Leptin deficiency down-regulates IL-23 production in glomerular podocytes resulting in an attenuated immune response in nephrotoxic serum nephritis[J]. Int Immunol, 2016, 28(4): 197-208.
12、 TIAN G, LIANG J H, WANG Z Y, et al. Emerging role of leptin in rheumatoid arthritis[J]. Clin Exp Immunol, 2014, 177(3): 557-570. TIAN G, LIANG J H, WANG Z Y, et al. Emerging role of leptin in rheumatoid arthritis[J]. Clin Exp Immunol, 2014, 177(3): 557-570.
13、 KWON H, PESSIN J E. Adipokines mediate inflammation and insulin resistance[J]. Front Endocrinol(Lausanne), 2013, 4(71):71. KWON H, PESSIN J E. Adipokines mediate inflammation and insulin resistance[J]. Front Endocrinol(Lausanne), 2013, 4(71):71.
14、 STEFANOVIC A, KOTUR-STEVULJEVIC J, SPASIC S,et al. The influence of obesity on the oxidative stress status and the concentration of leptin in type 2 diabetes mellitus patients[J]. Diabetes Res Clin Pract,2008, 79(1): 156-163. STEFANOVIC A, KOTUR-STEVULJEVIC J, SPASIC S,et al. The influence of obesity on the oxidative stress status and the concentration of leptin in type 2 diabetes mellitus patients[J]. Diabetes Res Clin Pract,2008, 79(1): 156-163.
15、 SINHA N, DABLA P K. Oxidative stress and antioxidants in hypertension-a current review[J]. Curr Hypertens Rev,2015, 11(2): 132-142. SINHA N, DABLA P K. Oxidative stress and antioxidants in hypertension-a current review[J]. Curr Hypertens Rev,2015, 11(2): 132-142.
16、 HAMED E A, ZAKAIY M M, AHMED N. et al. Circulating leptin and insulin in obese patients with and without type 2 diabetes mellitus: relation to ghrelin and oxidative steess[J]. D iabetes Res Clip Pract, 2011, 94(3):434-441. HAMED E A, ZAKAIY M M, AHMED N. et al. Circulating leptin and insulin in obese patients with and without type 2 diabetes mellitus: relation to ghrelin and oxidative steess[J]. D iabetes Res Clip Pract, 2011, 94(3):434-441.
17、 DAS UN. Renin-angiotensin-aldosterone system in insulin resistance and metabolic syndrome[J]. J Transl Int Med, 2016, 4(2): 66-72. DAS UN. Renin-angiotensin-aldosterone system in insulin resistance and metabolic syndrome[J]. J Transl Int Med, 2016, 4(2): 66-72.
18、 KOVESDY C P, FURTH S L, ZOCCALI C, et al. Obesity and kidney disease: Hidden consequences of the epidemic[J]. J Ren Care, 2017, 43(1): 3-10. KOVESDY C P, FURTH S L, ZOCCALI C, et al. Obesity and kidney disease: Hidden consequences of the epidemic[J]. J Ren Care, 2017, 43(1): 3-10.
19、 XUE H, WANG J L, HOU J H, et al. Prehypertension and chronic kidney disease in chinese population: four-year follow-up study[J]. PLoS One,2015, 10(12): e0144438. XUE H, WANG J L, HOU J H, et al. Prehypertension and chronic kidney disease in chinese population: four-year follow-up study[J]. PLoS One,2015, 10(12): e0144438.
20、 MARK A L. Selective Leptin resistance revisited[J]. Am J Physiol Regul Integr Comp Physiol, 2013, 305(6): 8566-8581. MARK A L. Selective Leptin resistance revisited[J]. Am J Physiol Regul Integr Comp Physiol, 2013, 305(6): 8566-8581.
21、 ARAGONES G, ARDID-RUIZ A, IBARS M, et al. Modulation of leptin resistance by food compound[J]. Mol Nutr Food Res, 2016, 60(8): 1789-1803. ARAGONES G, ARDID-RUIZ A, IBARS M, et al. Modulation of leptin resistance by food compound[J]. Mol Nutr Food Res, 2016, 60(8): 1789-1803.
22、 MUNZBERG H, MORRISON C D.Structure, production and signaling of leptin[J]. Metabolism, 2015, 64(1): 13-23. MUNZBERG H, MORRISON C D.Structure, production and signaling of leptin[J]. Metabolism, 2015, 64(1): 13-23.
23、 FOLCH J, PEDROS I, PATRACA I, et al. Neuroprotective and anti-ageing role of leptin[J]. J Mol Endocrinol, 2012, 49(3): 149-156. FOLCH J, PEDROS I, PATRACA I, et al. Neuroprotective and anti-ageing role of leptin[J]. J Mol Endocrinol, 2012, 49(3): 149-156.
24、 MORAES-VIEIRA P M, LAROCCA R A, BASSI E J, et al. Leptin deficiency impairs maturation of dendritic cells and enhances induction of regulatory T and Th17 cells[J]. Eur J lmmunol, 2014, 44(3):794-806. MORAES-VIEIRA P M, LAROCCA R A, BASSI E J, et al. Leptin deficiency impairs maturation of dendritic cells and enhances induction of regulatory T and Th17 cells[J]. Eur J lmmunol, 2014, 44(3):794-806.
25、 LA RUSSA D, BRUNELLI E, PELLEGRINO D. Oxidative imbalance and kidney damage in spontaneously hypertensive rats: activation of extrinsic apoptotic pathway[J]. Clin Sci (Lond), 2017, 131(13): 1419-1428. LA RUSSA D, BRUNELLI E, PELLEGRINO D. Oxidative imbalance and kidney damage in spontaneously hypertensive rats: activation of extrinsic apoptotic pathway[J]. Clin Sci (Lond), 2017, 131(13): 1419-1428.
26、 MCMASTER W G, KIRABO A, MADHUR M S, et al. Inflammation, immunity, and hypertensive end-organ damage[J]. Circ Res, 2015, 116(6): 1022-1033. MCMASTER W G, KIRABO A, MADHUR M S, et al. Inflammation, immunity, and hypertensive end-organ damage[J]. Circ Res, 2015, 116(6): 1022-1033.
27、 RODRIGUEZ-ITURBE B, PONS H, JOHNSON R J. Role of the Immune system in hypertension[J]. Physiol Rev,2017, 97(3): 1127-1164. RODRIGUEZ-ITURBE B, PONS H, JOHNSON R J. Role of the Immune system in hypertension[J]. Physiol Rev,2017, 97(3): 1127-1164.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录